Single Point Partners’s Medtronic MDT Stock Holding History

Single Point Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,992	Closed	-$264K	–	99
2023 Q2	$264K	Buy	+2,992	New	+$258K	0.36%	48

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Single Point Partners's MDT Position: Q3 2023 in Review

Single Point Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 2,992 shares — an estimated $264K sold.

Single Point Partners first reported a position in MDT in Q2 2023 and held it in 1 quarter. The position peaked at $264K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Single Point Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
Single Point Partners sold 2,992 Medtronic shares in Q3 2023, an estimated $264K.
Single Point Partners first reported a position in Medtronic in Q2 2023 and held it in 1 quarter.
Single Point Partners's Medtronic position peaked at $264K in Q2 2023.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Single Point Partners's 13F filing for Q3 2023, filed 12 Oct 2023.